WallStSmart
ASTH

Astrana Health Inc

NASDAQ: ASTH · HEALTHCARE · MEDICAL CARE FACILITIES

$37.97
+0.37% today

Updated 2026-06-05

Market cap
$1.87B
P/E ratio
61.67
P/S ratio
0.53x
EPS (TTM)
$0.61
Dividend yield
52W range
$18 – $40
Volume
0.5M

Astrana Health Inc (ASTH) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$100000.00$1.06M$2.44M$3.90M$5.11M$7.78M$10.48M$32.99M$44.05M$57.43M$357.75M$519.91M$560.62M$370.25M$773.91M$1.14B$1.39B$2.03B$3.18B
Revenue growth (YoY)+957.4%+130.9%+59.6%+31.2%+52.2%+34.8%+214.7%+33.5%+30.4%+523.0%+45.3%+7.8%-34.0%+109.0%+47.8%+21.2%+46.7%+56.4%
Cost of revenue$100000.00$1.05M$1.81M$3.31M$4.13M$6.32M$9.08M$22.07M$34.35M$48.74M$293.73M$380.44M$467.81M$348.54M$596.14M$944.68M$1.17B$1.76B$2.89B
Gross profit$11251.00$627508.00$581862.00$978407.00$1.46M$1.41M$10.92M$9.70M$8.69M$64.02M$139.47M$92.81M$21.70M$177.77M$199.48M$214.96M$271.39M$295.78M
Gross margin0.0%1.1%25.7%14.9%19.1%18.8%13.4%33.1%22.0%15.1%17.9%26.8%16.6%5.9%23.0%17.4%15.5%13.3%9.3%
R&D$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
SG&A$27484.00$36651.00$827287.00$694319.00$566649.00$1.38M$3.52M$5.29M$11.28M$11.28M$18.58M$26.25M$43.35M$41.48M$15.59M$62.08M$77.67M$112.60M$154.11M$217.26M
Operating income$-27484.00$-36651.00$-835816.00$-102515.00$4015.00$-413335.00$-2.08M$-3.91M$-694334.00$-6.58M$-10.54M$37.58M$92.23M$32.42M$6.09M$98.18M$104.27M$84.61M$89.35M$78.53M
Operating margin-36.7%-79.0%-4.2%0.1%-8.1%-26.7%-37.3%-2.1%-14.9%-18.3%10.5%17.7%5.8%1.6%12.7%9.1%6.1%4.4%2.5%
EBITDA$-27484.00$-36651.00$-816035.00$-66811.00$15213.00$-397904.00$-2.09M$-3.83M$-359900.00$-7.35M$-9.88M$68.87M$102.49M$48.85M$29.74M$100.66M$112.08M$123.69M$141.84M$124.27M
EBITDA margin-36.7%-77.2%-2.7%0.4%-7.8%-26.9%-36.5%-1.1%-16.7%-17.2%19.2%19.7%8.7%8.0%13.0%9.8%8.9%7.0%3.9%
EBIT$-27484.00$-36651.00$-835815.00$-102514.00$4015.00$-410493.00$-2.12M$-3.86M$-694334.00$-7.70M$-10.52M$49.79M$83.19M$30.57M$11.39M$83.14M$94.54M$105.94M$113.92M$78.53M
Interest expense$27484.00$36651.00$55200.00$53128.00$126431.00$304034.00$930176.00$679184.00$0.00$542296.00$82905.00$79689.00$560515.00$4.73M$2.53M$5.39M$7.92M$16.10M$33.10M$49.93M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-27484.00$-36651.00$-891815.00$-196080.00$-156331.00$-720346.00$-8.90M$-5.02M$-1.80M$-9.34M$-8.97M$25.80M$10.84M$14.12M$-23.75M$68.92M$45.17M$60.72M$43.15M$22.49M
Net income growth (YoY)-33.4%-2333.3%+78.0%+20.3%-360.8%-1136.2%+43.6%+64.1%-418.4%+4.0%+387.7%-58.0%+30.3%-268.3%+390.2%-34.5%+34.4%-28.9%-47.9%
Profit margin-36.7%-84.3%-8.0%-4.0%-14.1%-114.5%-47.9%-5.5%-21.2%-15.6%7.2%2.1%2.5%-6.4%8.9%3.9%4.4%2.1%0.7%

Frequently asked questions

What is Astrana Health Inc's revenue?

Astrana Health Inc's trailing twelve-month revenue is $3.53B. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is ASTH?

In its most recent fiscal year, ASTH ran a gross margin of 9.30%, an operating margin of 2.47%, and a net margin of 0.71%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does ASTH generate?

ASTH produced $104.49M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is ASTH's balance sheet healthy?

ASTH holds $429.47M in cash and equivalents against $990.90M in long-term debt, on $779.29M of shareholder equity. That debt is best read against the cash flow the business throws off each year.